DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▼ | UniProt ID |
---|---|---|---|---|---|
C0400966 | Non-alcoholic Fatty Liver Disease | SLC2A8 | 29988 | solute carrier family 2 member 8 | Q9NY64 |
C0011854 | Diabetes Mellitus, Insulin-Dependent | SLC2A8 | 29988 | solute carrier family 2 member 8 | Q9NY64 |
C0026764 | Multiple Myeloma | SLC2A8 | 29988 | solute carrier family 2 member 8 | Q9NY64 |
C0020676 | Hypothyroidism | SLC2A8 | 29988 | solute carrier family 2 member 8 | Q9NY64 |
C0027651 | Neoplasms | SLC2A8 | 29988 | solute carrier family 2 member 8 | Q9NY64 |
C0024523 | Malabsorption Syndrome | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C1257931 | Mammary Neoplasms, Human | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C0025517 | Metabolic Diseases | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C0028754 | Obesity | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C0678222 | Breast Carcinoma | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C0006142 | Malignant neoplasm of breast | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C0027651 | Neoplasms | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C1306459 | Primary malignant neoplasm | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C1140680 | Malignant neoplasm of ovary | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C0524620 | Metabolic Syndrome X | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C0023976 | Long QT Syndrome | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C0600139 | Prostate carcinoma | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C0007102 | Malignant tumor of colon | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C0006826 | Malignant Neoplasms | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C0152013 | Adenocarcinoma of lung (disorder) | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C0021828 | Intestinal Atresia | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C0020538 | Hypertensive disease | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C0024121 | Lung Neoplasms | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
C1458155 | Mammary Neoplasms | SLC2A5 | 6518 | solute carrier family 2 member 5 | P22732 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024